(RTTNews) - German stocks turned in a mixed performance on Monday with investors closely following the developments on the geopolitical front in addition to digesting regional economic data.
(RTTNews) - Vaxcyte, Inc. (PCVX) is set to present topline results from its pivotal Phase 3 OPUS-1 trial evaluating VAX-31, the company's 31-valent pneumococcal conjugate vaccine candidate, during a webcast and conference call scheduled for October 5, 2026.
(RTTNews) - Gold prices traded higher on Monday, recovering from an early slide as investors trimmed bets on an aggressive policy tightening cycle by the U.S. Federal Reserve.
(RTTNews) - Oil prices edged up slightly in volatile trade on Monday as investors weighed news of a planned release of emergency oil and diesel stocks by the Group of seven countries against renewed attacks around the Strait of Hormuz.
(RTTNews) - AbbVie (ABBV) on October 2, Friday announced that it has been approved to participate in the federal 340B Rebate Model Pilot Program, a government initiative aimed at improving pricing transparency and oversight within the long-running 340B drug discount program. The
(RTTNews) - Moberg Pharma AB (MOB.ST) announced the publication of new analyses in the Journal of Fungi, 2026 showing that Terbinafine maintained strong antifungal activity against dermatophytes, the fungi responsible for most nail fungus infections, while MOB-015 achieved fungal